Commentary: Hillman K, Chen J, et al. (2005). Introduction of the medical emergency team (MET) system: a cluster-randomised controlled trial.

Nurs Crit Care

Critical Care, Royal Berkshire NHS FoundationTrust, London Road, Reading, Berks, RG1 5AN, UK.

Published: January 2008

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-5153.2006.00205.xDOI Listing

Publication Analysis

Top Keywords

commentary hillman
4
hillman chen
4
chen 2005
4
2005 introduction
4
introduction medical
4
medical emergency
4
emergency team
4
team met
4
met system
4
system cluster-randomised
4

Similar Publications

Early investments in regional hydrogen systems carry two distinct types of risk: (1) economic risk that projects will not be financially viable, resulting in stranded capital, and (2) environmental risk that projects will not deliver deep reductions in greenhouse gas emissions and through leaks, perhaps even contribute to climate change. This article systematically reviews the literature and performs analysis to describe both types of risk in the context of recent efforts in the United States and worldwide to support the development of "hydrogen hubs" or regional systems of hydrogen production and use. We review estimates of hydrogen production costs and projections of how future costs are likely to change over time for different production routes, environmental impacts related to hydrogen and methane leaks, and the availability and effectiveness of carbon capture and sequestration.

View Article and Find Full Text PDF

Importance: Choosing Wisely recommendations advocate against routine use of axillary staging in older women with early-stage, clinically node-negative (cN0), hormone receptor-positive (HR+), and HER2-negative breast cancer. However, rates of sentinel lymph node biopsy (SLNB) in this population remain persistently high.

Objective: To evaluate whether an electronic health record (EHR)-based nudge intervention targeting surgeons in their first outpatient visit with patients meeting Choosing Wisely criteria decreases rates of SLNB.

View Article and Find Full Text PDF

PD-L1 as a predictive biomarker for pembrolizumab in HER2-positive gastric or gastro-esophageal junction adenocarcinoma-a commentary on KEYNOTE-811.

Chin Clin Oncol

August 2024

Division of Hematology & Oncology, Department of Medicine, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!